Anika Therapeutics reported $286.8M in Equity Capital and Reserves for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Acceleron Pharma XLRN:US $ 763.03M 47.8M
Acorda Therapeutics ACOR:US $ 190.48M 15.8M
Adamas Pharmaceuticals ADMS:US -4033000 9.97M
Agenus AGEN:US $ -228.84M 61.78M
Agios Pharmaceuticals AGIO:US $ 1721.82M 574.81M
Anika Therapeutics ANIK:US $ 286.8M 10.15M
Arrowhead Research ARWR:US $ 436.89M 8.66M
Chemocentryx CCXI:US $ 330.27M 30.73M
Clovis Oncology CLVS:US $ -206.98M 14.06M
Dicerna Pharmaceuticals DRNA:US $ 111.07M 15.33M
Enanta Pharmaceuticals ENTA:US $ 417.85M 18.18M
Flexion Therapeutics FLXN:US $ -56171000 17.3M
Halozyme Therapeutics HALO:US $ 119.75M 52.15M
Heron Therapeutics HRTX:US $ 160.11M 36.11M
Immunogen IMGN:US $ 68.46M 25.66M
Insmed INSM:US $ 531.05M 329.42M
Integra Lifesciences IART:US $ 1574.98M 45.65M
Intrexon XON:US $ 159.2M 15.6M
Karyopharm Therapeutics KPTI:US $ -83132000 43.49M
Ligand Pharmaceuticals LGND:US $ 786.52M 40.68M
Macrogenics MGNX:US $ 319.04M 31.49M
Merit Medical Systems MMSI:US $ 992.43M 15.74M
Peregrine Pharmaceuticals PPHM:US $ 44.64M 33.1M
Rigel Pharmaceuticals RIGL:US $ 68.11M 10.19M
Sangamo Biosciences SGMO:US $ 445.46M 24.9M
Stryker SYK:US $ 13820M 318M
Surmodics SRDX:US $ 140.83M 1.25M
Veracyte VCYT:US $ 971.18M 3.05M
Xencor XNCR:US $ 646.94M 63.33M
Zimmer Biomet Holdings Inc ZBH:US $ 12.58B 132.9M